4th Quarter - Report

TCH GROUP, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Extension of the U.S. R&D tax credit and all such provisions in HR4853 "Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010" and HR422 "To amend the Internal Revenue Code of 1986 to extend research credit through 2010 and to increase and make permanent the alternative simplified research credit"; and S1203 "Grow Research Opportunities with Tax Credits' Help Act" or "GROWTH Act"

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4853 (111th), H.R. 422 (111th)

Copyright/Patent/Trademark CPT

All provisions of S 369 "Preserve Access to Affordable Generics Act" and inlcuding this bill as amended to be included in S3677 "Financial Services and General Government Appropriations Act, 2011"

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Comparative effectiveness, including issues related to the Patient Centered Research Institute, and general issues regarding implementation of HR 3590 "The Patient Protection and Affordable Care Act"; information and awareness of the availability of new treatment options for cancer patients; and awareness and issues related to patient access to diabetes care.

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3590 (111th)

Medicare/Medicaid MMM

Issues related to the reimbursement of influenza vaccines in the Medicare Part B program.

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.